NL-201

· Neurogene Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NL-201, covering 2024-10-01 to 2024-10-01. Get the full timeline:

Most recent: Clinical Trial Update: NL-201 Monotherapy and in Combination With Pembrolizumab in Patients With Relapsed or Refractory Cancer [Phase 1]